Skip to main content

Table 2 Improvement of BCVA from baseline to follow-up visits in 2 groups

From: Efficacy of vision therapy for unilateral refractive amblyopia in children aged 7–10 years

Variables

Δ0–1

Δ0–2

Δ0–3

Δ0-E

control

case

P value

control

case

P value

control

case

P value

control

case

P value

logMAR

N = 13

N = 18

 

N = 6

N = 3

 

N = 1

N = 1

 

N = 17

N = 19

 
 

0.07 (0.18)

0.32 (0.20)

0.005*

0.12 (0.15)

0.23 (0.21)

0.356

0.30 (−)

0.40 (−)

–

0.12 (0.18)

0.29 (0.20)

0.006*

  1. Data presented as mean (SD). p value for two independent t test
  2. Δ0–1: Difference between 3rd month and baseline
  3. Δ0–2: Difference between 6th month and baseline
  4. Δ0–3: Difference between 9th month and baseline
  5. Δ0–4: Difference between 12th month and baseline
  6. Δ0-E: Difference between endpoint and baseline
  7. *represent P value less than 0.05
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us